Countries & territories / Lesser Antilles
The only CARICOM state we have identified with clinical trials primary legislation.
Population 180,149 (2025) · Part of the PCRA Group's UK, US and Caribbean network.
- Capital
- Castries
- Main languages
- English; Kwéyòl widely spoken
- Currency
- East Caribbean dollar (XCD)
- Population
- 180,149 (2025)
- Clinical Trials Act
- Primary legislation designating a National Competent Authority — we have found no equivalent elsewhere in CARICOM
- 33.7%
- Adult obesity, on the network's tightest confidence interval
- 120
- Beds at the Owen King EU Hospital, opened 2020
Why Saint Lucia
Saint Lucia is the one territory in this network with a Clinical Trials Act on the statute book, designating the Ministry of Health as National Competent Authority with the power to issue trial authorisations. It also has the tightest confidence intervals on its prevalence estimates in the Eastern Caribbean — a sign that real national survey data, not just modelling, sits underneath the numbers.
The disease burden
Saint Lucia's estimates are unusually well constrained — obesity 33.7% [30.6–36.8] against intervals ten points wide elsewhere in the Eastern Caribbean. For feasibility modelling that matters: you can size a screening population here with more confidence than almost anywhere else in the region.
Sites and infrastructure
- Owen King European Union Hospital, Castries — 120 beds including a six-bed ICU, theatres, MRI and laboratory; opened fully March 2020, EUR 50.85m EU-funded
- Victoria Hospital (1887), still operating alongside OKEU
- St Jude Hospital, Vieux Fort — statutory body serving the south of the island
Research heritage
The St Lucia Project (1965–1981), funded by the Rockefeller Foundation with the Government of Saint Lucia through a dedicated Research and Control Department of the Ministry of Health — the first large-scale concurrent comparison of drug-based against environmental control of Schistosoma mansoni, using the island's geographically isolated valleys as parallel study arms. A 2020 national survey found evidence that transmission had been interrupted. This is heritage rather than current capability: the infrastructure was decommissioned decades ago. But it establishes that large controlled studies have been run successfully on this island before.
Regulatory & ethics
- Clinical Trials Act — section 7 designates the Ministry of Health as National Competent Authority, with power to issue authorisations, monitor and enforce
- Section 11 requires an Ethics Committee opinion; sections 13 and 15 govern application for and grant of authorisation
- Section 6 provides for a statutory Ethics Committee of 7–11 members appointed by the Minister with Cabinet approval
The honest position: The Act exists, but there is no published evidence that an Ethics Committee has been appointed and is sitting, no published authorisation guidance, and no fee or timeline schedule. A sponsor could file into a statutory process that has never been exercised. Note also that PAHO's Pharmaceutical Country Profile still states no authorisation requirement exists — that profile appears not to reflect the Act. We establish the live position with the Ministry before committing a protocol, and we tell you what we find.
Data quality: Strong relative to peers — the tightest confidence intervals in the Eastern Caribbean and the only territory with clinical trial primary legislation.
How this site fits the network
Core network site — strong population proposition with a functioning ethics route; research infrastructure developing.
Our Saint Lucia operation is contracted, trained and monitored under the same quality system as our UK and US sites. One master service agreement covers all three regions, one budget negotiation, one set of payment terms. Sites in this network can absorb enrolment from under-recruiting UK or US centres without a new vendor qualification cycle.
Key indicators
| Indicator | Value | Basis |
|---|---|---|
| Adult obesity (BMI ≥30) | 33.7% | Crude, adults 18+, 2022 |
| Adults overweight or obese | 63.1% | Crude, adults 18+, 2022 |
| Adult diabetes | 20.4% | Crude, adults 18+, 2022 |
| Hypertension | 39.8% | Age-standardised, 30–79, 2019 |
| — of whom controlled | 22.0% | Age-standardised, 2019 |
| NCDs as share of all deaths | 82.1% | 2019 |
| Premature NCD mortality (30–70) | 15.5% | Probability of death, 2021 |
All figures are WHO Global Health Observatory modelled estimates on one consistent basis: obesity, overweight and diabetes are crude prevalence, adults 18+, 2022; hypertension and control are age-standardised, adults 30–79, 2019; NCD share of deaths is 2019; premature NCD mortality is the probability of dying between 30 and 70 from a major NCD, 2021. Estimates carry confidence intervals — we quote intervals on request and always where they are wide.
Member sites in Saint Lucia
Our anonymised directory shows the network's research-ready sites — sponsors can register for full site details, including which countries and territories each site serves.
Browse member sitesPlanning a study in Saint Lucia?
Tell us what your protocol needs and we'll give you an honest feasibility read — and if you run a hospital, clinic, pharmacy, lab or research unit in Saint Lucia, we'd love to hear from you too.